Custom service
Custom Antibody Labeling
Enzyme, fluorophore, biotin or gold — attached where it does not block binding.
A conjugate is a compromise between signal and binding. Label too lightly and the assay loses sensitivity; label too heavily and lysines in the CDRs are modified, the antibody aggregates, and the antigen-binding site is sterically obstructed. The work is in finding the ratio at which the conjugate performs, and in choosing chemistry that does not touch the paratope.
Random amine labelling through surface lysines is the default for HRP and most fluorophores: simple, robust, and adequate for polyclonals and for antibodies whose CDRs contain few lysines. Site-directed labelling is better where it matters — thiol coupling to hinge cysteines after mild reduction, enzymatic labelling through a genetically encoded tag, or glycan oxidation — because it keeps the label away from the binding site and gives a defined stoichiometry.
Every lot is characterised before release. Degree of labelling is measured spectrophotometrically for fluorophores and by MALDI-TOF or SEC for proteins; enzyme activity is measured against a chromogenic substrate; and the conjugate is titrated in the intended assay so that the working dilution is known rather than guessed.
Service Highlights
Where it fits
Custom labelling is used when a commercial conjugate does not exist for a clone, when the dye must match a specific laser and filter set, and when the assay demands a defined DAR — quantitative flow cytometry, for example, where the fluorescence per cell must be interpretable.
It is not a solution for a poorly performing antibody. Labelling amplifies whatever the antibody already does, including non-specific binding, and a conjugate made from a bad clone is a brighter bad clone.
Documentation and QC
Each lot is released with DAR, SEC-HPLC monomer and aggregate content, binding activity relative to the unlabelled parent, and a titration curve in the intended application. Free label is verified to be below 5% by SEC.
Frequently asked questions
Which DAR should we choose?
For flow cytometry, 2–4 dyes per IgG gives a good signal without quenching; for Western blot, HRP at 1–3 is standard; for IHC, lower labelling reduces background. We titrate rather than assume.
Can you label a Fab or a VHH?
Yes, and the lower lysine content often makes site-directed chemistry easier. For VHHs, a C-terminal cysteine or a sortase tag gives clean single-label products.
Will labelling reduce affinity?
Random lysine labelling can, if a lysine sits in or near a CDR. We compare binding before and after conjugation, and switch to a site-directed method if activity drops below 70%.
Tell us the instrument and the assay. The label and the DAR follow from that, and we will report the working dilution rather than leave you to find it.
Service Highlights
- Chemistry matched to the label. NHS-ester for amines, maleimide for thiols, hydrazide for glycans, and streptavidin-biotin for indirect formats.
- Site-directed options. Hinge thiol coupling, Fc-glycan labelling and tag-mediated enzymatic conjugation keep the paratope clear.
- Measured DAR. Dye-to-protein ratio reported per lot, with the labelling reaction tuned to the application rather than to a fixed protocol.
- Function retained. Binding ELISA compared against the unlabelled parent, with a minimum 70% retained activity for release.
- Aggregate control. SEC-HPLC after conjugation, because cross-linked aggregates are the usual cause of high background in IHC.
- Tandem and metal labels. PE, APC, PerCP and europium chelates for flow and TR-FRET applications.
How the work runs
Label and format selection
Application, instrument and required sensitivity decide the label. Flow cytometry, Western blot, IHC and TR-FRET each impose different constraints on DAR and on dye chemistry.
Buffer exchange
The antibody is moved into a labelling-compatible buffer free of amines, azide and carrier protein, which otherwise compete for the reactive group.
Conjugation
Molar excess of label titrated in a small pilot reaction; the ratio that gives the target DAR without aggregation is scaled up.
Purification of conjugate
Size-exclusion or affinity purification removes free dye, which otherwise produces background that cannot be blocked.
Characterisation
DAR by absorbance or MALDI-TOF, aggregation by SEC-HPLC, enzyme activity where relevant, and binding by ELISA.
Application titration
The conjugate is titrated in the intended assay and the recommended working range is reported with the lot.
Specifications & timeline
- Labels
- HRP, AP, FITC — Alexa, Cy, biotin, gold
- Dar
- 1–8 — measured per lot
- Timeline
- 1–2 weeks — including activity QC
- Labels
- HRP, alkaline phosphatase, FITC, Alexa Fluor 488/555/647, Cy3/Cy5, PE, APC, biotin, colloidal gold, europium
- Chemistry
- NHS-ester, maleimide, hydrazide, click chemistry, streptavidin bridging
- DAR
- Typically 2–6 for fluorophores, 1–3 for enzymes, measured per lot
- Starting material
- 0.2–20 mg purified IgG or fragment
- Timeline
- 1–2 weeks including pilot conjugation and QC
- Deliverables
- 0.2–20 mg conjugate, DAR, SEC-HPLC, binding data, recommended working dilution
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.